Influence of sociodemographic variables and tobacco consumption on the prevalence of atherogenic dyslipidemia and lipid triad in 418.343 spanish workers

• José Ignacio Ramírez-Manent ^{[1] [2] [4] [5]} ; Pilar Tomás-Gil ^[2] ; Josep Lluis Coll Villalonga ^[2] ; Pau Marti-Lliteras ^[2] ; Ángel Arturo López-González ^{[2] [3] [4]} ; Hernán Paublini ^[2]
  1. [1] Universitat de les Illes Balears

     Universitat de les Illes Balears

     Palma de Mallorca, España

     
  2. [2] Investigation Group ADEMA SALUD IUNICS, 07003 Palma, Balearic Islands, Spain
  3. [3] Faculty of Dentistry, University School ADEMA, 07009 Palma, Balearic Islands, Spain
  4. [4] IDISBA, Balearic Islands Health Research Institute Foundation, 07004 Palma, Balearic Islands, Spain
  5. [5] General Practitioner Department, Balearic Islands Health Service, 07003 Palma, Balearic Islands, Spain

  Mostrar afiliaciones +
• Localización: Academic Journal of Health Sciences: Medicina Balear, ISSN-e 2255-0560, Vol. 38, Nº. 6, 2023, págs. 84-89
• Idioma: inglés
• DOI: 10.3306/AJHS.2023.38.06.84
• Títulos paralelos:
  • Influencia de variables sociodemográficas y consumo de tabaco en la prevalencia de dislipemia aterogénica y triada lipídica en 418343 trabajadores españoles
• Enlaces
  • Texto completo (pdf)
• Resumen
  • español

    Introducción y objetivo: La aterosclerosis se ve influenciada por muchos factores como pueden ser la obesidad, la dislipemia, la hipertensión arterial, la diabetes, el sexo o la edad. La dislipemia aterogénica (DA) y la triada lipídica (TL) son indicadores de aterosclerosis. El objetivo de este estudio es conocer la influencia de variables sociodemográfica y consumo de tabaco sobre la aparición de DA y TL.

    Material y métodos: Estudio realizado en 418343 trabajadores españoles con una edad media de 40,2 años en el que se valoran variables sociodemográficas como la edad, sexo y clase social y su influencia sobre la prevalencia de DA y TL.

    Resultados: La prevalencia global de DA es del 6,19% (7,33% en hombres y 3,98% en mujeres) y la de TL del 1,70% (2,9% en hombres y 1% en mujeres). Todas las variables analizadas muestran su influencia sobre la aparición de DA y TL especialmente la edad.

    Conclusiones. La prevalencia de DA y TL es de 6,19% y 1,70% respectivamente. Aunque todas las variables influyen en la aparición de DA y TL la que muestra unos valores mayores es la edad.

  • English

    Introduction and objective: Atherosclerosis is influenced by many factors such as obesity, dyslipidemia, arterial hypertension, diabetes, sex or age. Atherogenic dyslipidemia (AD) and lipid triad (LT) are indicators of atherosclerosis. The aim of this study was to determine the influence of sociodemographic variables and tobacco consumption on the appearance of AD and LT.

    Material and methods: Study carried out in 418343 Spanish workers with a mean age of 40.2 years in which sociodemographic variables such as age, sex and social class and their influence on the prevalence of AD and LT were assessed.

    Results: The overall prevalence of AD was 6.19% (7.33% in men and 3.98% in women) and that of TL was 1.70% (2.9% in men and 1% in women). All the variables analyzed show their influence on the occurrence of AD and TL, especially age.

    Conclusions: The prevalence of AD and TL is 6.19% and 1.70% respectively. Although all the variables influence the appearance of AD and TL, the one that shows the highest values is age.

• Referencias bibliográficas
  • Li J, Wang K, Pan W, Li N, Tang B. Targeted Imaging in Atherosclerosis. Anal Chem. 2022 Sep 13;94(36):12263-12273. doi: 10.1021/acs. analchem.2c02644.
  • Kim K, Park SE, Park JS, Choi JH. Characteristics of plaque lipidassociated macrophages and their possible roles in the pathogenesis of atherosclerosis....
  • Meng H, Ruan J, Yan Z, Chen Y, Liu J, Li X, et al. New Progress in Early Diagnosis of Atherosclerosis. Int J Mol Sci. 2022 Aug 11;23(16):8939....
  • Puylaert P, Zurek M, Rayner KJ, De Meyer GRY, Martinet W. Regulated Necrosis in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2022 Nov;42(11):1283-1306....
  • Zhang X, Ren Z, Xu W, Jiang Z. Necroptosis in atherosclerosis. Clin Chim Acta. 2022 Sep 1;534:22-28. doi: 10.1016/j.cca.2022.07.004.
  • Qin W, Gan F, Liang R, Li J, Lai X, Dai Y, et al. Identification of Monocyte-Associated Genes Related to the Instability of Atherosclerosis Plaque....
  • Fang F, Xiao C, Li C, Liu X, Li S. Tuning macrophages for atherosclerosis treatment. Regen Biomater. 2022 Dec 13;10:rbac103. doi: 10.1093/rb/ rbac103.
  • Wang C, Liu C, Shi J, Li H, Jiang S, Zhao P, et al. Nicotine exacerbates endothelial dysfunction and drives atherosclerosis via extracellular...
  • Kadoglou NPE, Moulakakis KG, Mantas G, Kakisis JD, Mylonas SN, Valsami G, et al. The Association of Arterial Stiffness With Significant Carotid...
  • Yu M, Zhang S, Wang L, Wu J, Li X, Yuan J. Metabolically Healthy Obesity and Carotid Plaque among Steelworkers in North China: The Role of...
  • Aengevaeren VL, Mosterd A, Bakker EA, Braber TL, Nathoe HM, Sharma S, et al. Exercise Volume Versus Intensity and the Progression of Coronary...
  • Richardson LA, Izuora K, Basu A. Mediterranean Diet and Its Association with Cardiovascular Disease Risk Factors: A Scoping Review. Int J...
  • Benincasa G, Coscioni E, Napoli C. Cardiovascular risk factors and molecular routes underlying endothelial dysfunction: Novel opportunities for...
  • Ras J, Smith DL, Kengne AP, Soteriades EE, Leach L. Cardiovascular Disease Risk Factors, Musculoskeletal Health, Physical Fitness, and Occupational...
  • Rosenthal T, Touyz RM, Oparil S. Migrating Populations and Health: Risk Factors for Cardiovascular Disease and Metabolic Syndrome. Curr Hypertens...
  • Pascual V, Díaz JL, Millán Nuñez-Cortés J, Pérez-Martínez P. Nutritional recommendations in the prevention and treatment of atherogenic dyslipidemia....
  • Paublini H, López González AA, Busquets-Cortés C, Tomas-Gil P, Riutord-Sbert P, Ramírez-Manent JI. Relationship between Atherogenic Dyslipidaemia...
  • Domingo-Salvany A, Bacigalupe A, Carrasco JM, Espelt A, Ferrando J, Borrell C, et al. Propuestas de clase social neoweberiana y neomarxista...
  • Cabrera M, Sánchez-Chaparro MA, Valdivielso P, Quevedo-Aguado L, Catalina-Romero C, Fernández-Labandera C, et al. Prevalence of atherogenic...
  • Zhao W, Zheng XL, Jiang ZN, Liao XB, Zhao SP. Risk factors associated with atherogenic dyslipidemia in the presence of optimal statin therapy....
  • Liu X, Yu S, Mao Z, Li Y, Zhang H, Yang K, et al. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural...
  • Mohammed O, Alemayehu E, Ebrahim E, Fiseha M, Gedefie A, Ali A, et al. Atherogenic dyslipidemia and associated risk factors among hypertensive...
  • Opoku S, Gan Y, Fu W, Chen D, Addo-Yobo E, Trofimovitch D, et al. Prevalence and risk factors for dyslipidemia among adults in rural and urban China:...
  • Wang M, Liu M, Li F, Guo C, Liu Z, Pan Y, et al. Gender heterogeneity in dyslipidemia prevalence, trends with age and associated factors in middle...
  • Názara C, Argüeso RM, Pedro-Botet J, Pintó X, Millán J, Pena Seijo M, et al. Prevalence of atherogenic dyslipidemia, related factors and level of...
  • Pedro-Botet J, Flores-Le Roux JA, Mostaza JM, Pintó X, de la Cruz JJ, Banegas JR; en nombre del grupo de investigadores EDICONDISULISEA. Atherogenic...